Type 1 insulin-like growth factor receptor targeted therapies in pediatric cancer.
about
GALNT2 suppresses malignant phenotypes through IGF-1 receptor and predicts favorable prognosis in neuroblastoma.IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas.Molecular profiling of childhood cancer: Biomarkers and novel therapiesDissecting the PI3K Signaling Axis in Pediatric Solid Tumors: Novel Targets for Clinical Integration.Therapy resistance mechanisms in Ewing's sarcoma family tumors.Vincristine, Ifosfamide, and Doxorubicin for Initial Treatment of Ewing Sarcoma in Adults.
P2860
Type 1 insulin-like growth factor receptor targeted therapies in pediatric cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Type 1 insulin-like growth factor receptor targeted therapies in pediatric cancer.
@en
Type 1 insulin-like growth factor receptor targeted therapies in pediatric cancer.
@nl
type
label
Type 1 insulin-like growth factor receptor targeted therapies in pediatric cancer.
@en
Type 1 insulin-like growth factor receptor targeted therapies in pediatric cancer.
@nl
prefLabel
Type 1 insulin-like growth factor receptor targeted therapies in pediatric cancer.
@en
Type 1 insulin-like growth factor receptor targeted therapies in pediatric cancer.
@nl
P2860
P356
P1476
Type 1 insulin-like growth factor receptor targeted therapies in pediatric cancer
@en
P2093
Michael J Wagner
P2860
P356
10.3389/FONC.2013.00009
P577
2013-02-04T00:00:00Z